top of page

RNA-BASED THERAPY

  • RNA drugs potentially allow precise silencing or activation of genes
     

  • Advanced antisense RNA drugs enable precise control of gene expression, addressing diseases such as Huntington’s, DMD and SMA
     

  • Very rapid bioinformatics-based drug design cycles

THERAPEUTIC AREAS

  • Virology

  • Gain-of-function disorders

  • Liver disorders

  • Autoimmune disease

Invest_europe.png
4BIO Capital is a trading name of 4BIO Partners LLP which is authorised and regulated by the Financial Conduct Authority (Reference Number 842764)

4BIO Partners LLP is an SEC Registered Investment Advisor number 801-121342
© 2015-2024 by 4BIO Partners LLP
bottom of page